National Health Investors, Inc. NHI

66.92 (0.24) (0.36%) as of 25 Sep
Market cap
$3.3B
P/E
19.3×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
19.22 19.43 20.47 22.14 16.71 23.55 35.94 17.79 22.07 25.20
P/S ratio
11.71 11.12 10.75 11.12 9.29 8.80 8.50 7.55 9.07 9.53
P/FCF ratio
0.00 136.21 52.61 938.63 19.94 6.58 6.89 12.59 54.24 0.00
P/Operating CF
61.48 59.44 61.46 63.01 55.58 49.24 51.03 45.40 52.78 52.85
P/B ratio
2.41 2.34 2.28 2.36 2.03 1.73 1.85 1.91 2.21 2.34
Price to Tangible BV
2.41 2.34 2.28 2.36 2.03 1.73 1.85 1.91 2.21 2.34
EV/Sales
16.18 15.22 15.09 15.63 13.66 12.83 12.56 11.03 12.41 12.58
EV/EBITDA
17.92 15.69 15.90 16.58 14.55 17.51 21.42 14.01 15.93 16.75
EV/Operating CF
22.76 21.41 21.39 20.64 19.59 18.18 18.85 19.13 20.02 19.97
EV/FCF
(21.12) 186.42 73.82 1,319.43 29.33 9.60 10.18 18.38 74.27 (82.20)
Quick Ratio
3.70 6.16 5.54 3.47 5.52 5.76 3.71 3.12 2.95 2.25
Current Ratio
10.09 14.84 17.92 16.40 17.13 18.70 12.71 10.27 10.07 6.90
Net Debt/EBITDA
4.95 4.23 4.57 4.79 4.66 5.51 6.92 4.42 4.29 4.06
Debt/Assets
46.43% 45.00% 46.60% 47.35% 48.05% 43.78% 45.76% 45.61% 43.84% 41.61%
Debt/Equity
0.92 0.87 0.92 0.96 0.98 0.82 0.90 0.90 0.83 0.76
Asset Turnover
0.11 0.11 0.11 0.11 0.11 0.10 0.10 0.13 0.13 0.14
Operating CF/Net income
1.17 1.24 1.35 1.50 1.25 1.89 2.79 1.36 1.51 1.67
Capex/Depreciation
(5.88) (2.42) (1.96) (2.88) (0.87) 2.21 1.93 0.10 (1.95) (3.41)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
12.89% 12.59% 11.38% 11.11% 12.26% 7.36% 4.75% 10.66% 10.45% 9.77%
ROA
6.68% 6.44% 5.83% 5.54% 6.01% 3.75% 2.48% 5.43% 5.40% 5.25%
ROIC
4.36% 5.02% 4.78% 4.64% 4.70% 3.06% 2.11% 4.66% 4.59% 4.57%
Return on Tangible Assets
6.45% 6.35% 5.71% 5.41% 6.02% 4.10% 2.74% 5.59% 5.40% 5.20%
Average Days of Receivables
106.53 127.53 130.85 98.74 104.96 117.54 100.89 96.68 94.90 76.66
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
4.10% 4.56% 4.36% 4.37% 4.37% 6.47% 9.10% 6.20% 6.50% 7.86%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.70% 0.94% 0.85% 1.15% 0.92% 2.82% 3.10% 1.44% 1.25% 1.48%
Graham Net Nets
(0.34) (0.32) (0.32) (0.31) (0.38) (0.34) (0.38) (0.36) (0.28) (0.27)
Graham Number
52.03 53.26 52.45 53.45 56.34 42.68 30.75 45.30 47.08 47.17
Earnings Yield
5.20% 5.15% 4.88% 4.52% 5.99% 4.25% 2.78% 5.62% 4.53% 3.97%
Free Cash Flow Yield
(6.54%) 0.73% 1.90% 0.11% 5.02% 15.20% 14.51% 7.95% 1.84% (1.61%)
Revenue per Share
6.37 6.81 7.02 7.33 7.45 6.53 6.21 7.37 7.64 8.01
Operating CF per Share
4.53 4.84 4.96 5.55 5.19 4.61 4.14 4.25 4.74 5.05
Capex per Share
(9.41) (4.29) (3.52) (5.46) (1.72) 4.12 3.53 0.17 (3.46) (6.27)
Free Cash Flow per Share
(4.88) 0.56 1.44 0.09 3.47 8.74 7.67 4.42 1.28 (1.23)
Cash per Share
0.12 0.07 0.11 0.12 0.97 0.82 0.43 0.52 0.55 0.42
Shareholders Equity per Share
31.00 32.33 33.13 34.51 34.07 33.18 28.59 29.14 31.37 32.63
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
31.00 32.33 33.13 34.51 34.07 33.18 28.59 29.14 31.37 32.63
Free Cash Flow
(190.38) 22.75 60.22 3.77 155.06 399.38 343.31 191.93 56.02 (57.47)
Working Capital
189.77 225.61 336.50 405.09 406.29 410.38 303.42 318.03 342.61 258.08
Capital Expenditures
(367.01) (175.34) (147.64) (237.19) (77.09) 188.52 157.97 7.48 (151.75) (294.03)
Net Current Asset Value
(983.40) (981.80) (1,004.47) (1,112.58) (1,166.07) (888.33) (898.02) (871.76) (858.62) (965.37)
EV/EBIT
24.84 21.44 21.78 22.86 20.31 28.73 43.00 19.92 22.71 24.15
Capex to Sales
1.48 0.63 0.50 0.75 0.23 (0.63) (0.57) (0.02) 0.45 0.78
Net Profit Margin
60.99% 57.19% 52.39% 50.45% 55.62% 37.43% 23.87% 42.40% 41.13% 37.80%
Price to Operating Income
17.97 15.67 15.52 16.26 13.81 19.70 29.11 13.64 16.59 18.30
Other line items
Depreciation/Fixed assets
0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.03
Cash ROIC
(85.11%) (84.50%) (80.68%) (78.79%) (79.44%) (75.32%) (78.99%) (79.39%) (78.70%) (82.46%)
Accounts Receivable Turnover
3.76 3.28 2.90 3.32 3.66 3.11 3.21 3.96 3.90 4.52
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 1.15 1.32 1.17 1.50
Inventory Turnover
— — — — — — 0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 0.00 335.38 316.29 326.18 262.00
Days of Inventory on Hand
— — — — — — 0.00 0.00 0.00 0.00
Average Receivables
66.15 84.94 101.49 95.83 90.87 95.95 86.55 80.80 85.93 83.02
Average Payables
20.51 18.59 18.10 23.10 25.75 24.19 24.54 30.10 36.03 40.75
Average Assets
2,268.43 2,474.73 2,648.20 2,896.40 3,081.36 2,979.68 2,673.15 2,497.95 2,551.43 2,705.63
Average Common Equity
1,176.03 1,265.85 1,355.92 1,443.98 1,510.60 1,519.96 1,398.53 1,272.24 1,319.89 1,452.55

Fold the line items

Columns are period end dates